Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-23-014924
Filing Date
2023-04-27
Accepted
2023-04-26 17:41:46
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-27

Document Format Files

Seq Description Document Type Size
1 ARS ovid_ars_2022_wrap.pdf ARS 1374620
  Complete submission text file 0000950170-23-014924.txt   1894533
Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38085 | Film No.: 23851034
SIC: 2834 Pharmaceutical Preparations